Evidence map›Paper›PMID 35054342›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section.

Flavio Maria Ceci, Marco Fiore, Francesca Gavaruzzi, Antonio Angeloni, Marco Lucarelli, Carolina Scagnolari, Enea Bonci, Francesca Gabanella, Maria Grazia Di Certo, Christian Barbato and 10 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Are the thorax Computed Tomography findings of ICU patients diagnosed with COVID-19 pneumonia related to the duration of hospital stay and mortality?Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Flavio Maria CeciDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0001-7744-218X
Marco FioreInstitute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0001-6806-9715
Francesca GavaruzziDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Roma, Italy.
Antonio AngeloniDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.
Marco LucarelliDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0002-5538-2494
Carolina ScagnolariLaboratory of Virology, Department of Molecular Medicine, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0003-1044-1478
Enea BonciDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0003-3325-1124
Francesca GabanellaInstitute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.
Maria Grazia Di CertoInstitute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.
Christian BarbatoInstitute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0003-1737-9064
Carla PetrellaInstitute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0003-0651-1816
Antonio GrecoDepartment of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.
Marco De VincentiisDepartment of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.
Massimo RalliDepartment of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0001-8776-0421
Claudio PassanantiInstitute of Molecular Biology and Pathology (IBPM-CNR), 00185 Rome, Italy.
Roberto PosciaUnita di Ricerca Clinica e Clinical Competence-Direzione Generale, AOU Policlinico Umberto I, 00161 Roma, Italy.
Antonio MinniDepartment of Sensory Organs, Sapienza University of Rome, 00185 Roma, Italy.
Mauro CeccantiSocietà Italiana per il Trattamento dell'Alcolismo e le sue Complicanze (SITAC), 00184 Roma, Italy.
Luigi TaraniDepartment of Pediatrics, Sapienza University of Rome, 00185 Roma, Italy.ORCID 0000-0001-5958-9364
Giampiero FerragutiDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.
Sapienza University of Rome · ITInstitute of Molecular Biology and Pathology · ITIstituto Pasteur · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 is a severe acute respiratory disease caused by SARS-CoV-2, a virus belonging to the Coronaviridae family. This disease has spread rapidly around the world and soon became an international public health emergency leading to an unpredicted pressure on the hospital emergency units. Early routine blood biomarkers could be key predicting factors of COVID-19 morbidity and mortality as suggested for C-reactive protein (CRP), IL-6, prothrombin and D-dimer. This study aims to identify other early routine blood biomarkers for COVID-19 severity prediction disclosed directly into the emergency section.

methodsOur research was conducted on 156 COVID-19 patients hospitalized at the Sapienza University Hospital "Policlinico Umberto I" of Rome, Italy, between March 2020 and April 2020 during the paroxysm's initial phase of the pandemic. In this retrospective study, patients were divided into three groups according to their outcome: (1) emergency group (patients who entered the emergency room and were discharged shortly after because they did not show severe symptoms); (2) intensive care unit (ICU) group (patients who attended the ICU after admission to the emergency unit); (3) the deceased group (patients with a fatal outcome who attended the emergency and, afterward, the ICU units). Routine laboratory tests from medical records were collected when patients were admitted to the emergency unit. We focused on Aspartate transaminase (AST), Alanine transaminase (ALT), Lactate dehydrogenase (LDH), Creatine kinase (CK), Myoglobin (MGB), Ferritin, CRP, and D-dimer.

resultsAs expected, ANOVA data show an age morbidity increase in both ICU and deceased groups compared with the emergency group. A main effect of morbidity was revealed by ANOVA for all the analyzed parameters with an elevation between the emergency group and the deceased group. Furthermore, a significant increase in LDH, Ferritin, CRP, and D-dimer was also observed between the ICU group and the emergency group and between the deceased group and ICU group. Receiver operating characteristic (ROC) analyses confirmed and extended these findings.

conclusionsThis study suggests that the contemporaneous presence of high levels of LDH, Ferritin, and as expected, CRP, and D-dimer could be considered as potential predictors of COVID-19 severity and death.

Indexed as

biomarkerCOVID-19early predictoremergency sectionintensive care unitmorbiditymortalitySARS-CoV-2

Identifiers

PMID35054342
PMCPMC8774587
OpenAlexW4206222792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.